NM_005559.4:c.8062_8068dupAGCAAGC
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_005559.4(LAMA1):c.8062_8068dupAGCAAGC(p.Leu2690GlnfsTer42) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005559.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome Pathogenic:1
The p.Leu2690GlnfsX42 (NM_005559.3 c.8062_8068dupAGCAAGC) variant in LAMA1 has not been previously reported in the literature and was absent from large populat ion studies. This variant is predicted to cause a frameshift, which alters the p rotein?s amino acid sequence beginning at position 2690 and leads to a premature termination codon 42 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Biallelic loss of function of the LAMA 1 gene has been associated with Poretti-Boltshauser syndrome. In summary, althou gh additional studies are required to fully establish a null effect on the prote in, the p.Leu2690GlnfsX42 variant in the LAMA1 gene is likely pathogenic for Por etti-Boltshauser syndrome in an autosomal recessive manner based on its predicte d impact on the protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at